Comparison of peripheral and central schizophrenia biomarker profiles.

We have recently shown that a molecular biomarker signature comprised of inflammatory, hormonal and growth factors occurs in the blood serum from first onset schizophrenia patients. Here, we use the same platform to investigate post mortem brain tissue (Brodmann area 10) from schizophrenia patients...

Full description

Bibliographic Details
Main Authors: Laura W Harris, Sandra Pietsch, Tammy M K Cheng, Emanuel Schwarz, Paul C Guest, Sabine Bahn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3484150?pdf=render
id doaj-71868fd040e741eaa72d14fdcedca0ac
record_format Article
spelling doaj-71868fd040e741eaa72d14fdcedca0ac2020-11-25T01:53:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4636810.1371/journal.pone.0046368Comparison of peripheral and central schizophrenia biomarker profiles.Laura W HarrisSandra PietschTammy M K ChengEmanuel SchwarzPaul C GuestSabine BahnWe have recently shown that a molecular biomarker signature comprised of inflammatory, hormonal and growth factors occurs in the blood serum from first onset schizophrenia patients. Here, we use the same platform to investigate post mortem brain tissue (Brodmann area 10) from schizophrenia patients who were mainly chronically ill and drug treated. Twenty-one analytes are differentially expressed in post-mortem brain tissue. Comparison with our previous mRNA profiling studies of the same patient samples in another frontal cortical area showed that 9 of these molecules were also altered at the transcriptional level. Furthermore, 9 of the molecules were also altered in serum from living first onset schizophrenia patients compared to controls. We propose a model in which the brain and periphery are coordinated through hormones and other regulatory molecules released into the blood via the diffuse neuroendocrine system. These findings provide further evidence for the systemic nature of schizophrenia and give added validity to the concept that schizophrenia can be investigated through studies of blood-based biomarkers.http://europepmc.org/articles/PMC3484150?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Laura W Harris
Sandra Pietsch
Tammy M K Cheng
Emanuel Schwarz
Paul C Guest
Sabine Bahn
spellingShingle Laura W Harris
Sandra Pietsch
Tammy M K Cheng
Emanuel Schwarz
Paul C Guest
Sabine Bahn
Comparison of peripheral and central schizophrenia biomarker profiles.
PLoS ONE
author_facet Laura W Harris
Sandra Pietsch
Tammy M K Cheng
Emanuel Schwarz
Paul C Guest
Sabine Bahn
author_sort Laura W Harris
title Comparison of peripheral and central schizophrenia biomarker profiles.
title_short Comparison of peripheral and central schizophrenia biomarker profiles.
title_full Comparison of peripheral and central schizophrenia biomarker profiles.
title_fullStr Comparison of peripheral and central schizophrenia biomarker profiles.
title_full_unstemmed Comparison of peripheral and central schizophrenia biomarker profiles.
title_sort comparison of peripheral and central schizophrenia biomarker profiles.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description We have recently shown that a molecular biomarker signature comprised of inflammatory, hormonal and growth factors occurs in the blood serum from first onset schizophrenia patients. Here, we use the same platform to investigate post mortem brain tissue (Brodmann area 10) from schizophrenia patients who were mainly chronically ill and drug treated. Twenty-one analytes are differentially expressed in post-mortem brain tissue. Comparison with our previous mRNA profiling studies of the same patient samples in another frontal cortical area showed that 9 of these molecules were also altered at the transcriptional level. Furthermore, 9 of the molecules were also altered in serum from living first onset schizophrenia patients compared to controls. We propose a model in which the brain and periphery are coordinated through hormones and other regulatory molecules released into the blood via the diffuse neuroendocrine system. These findings provide further evidence for the systemic nature of schizophrenia and give added validity to the concept that schizophrenia can be investigated through studies of blood-based biomarkers.
url http://europepmc.org/articles/PMC3484150?pdf=render
work_keys_str_mv AT laurawharris comparisonofperipheralandcentralschizophreniabiomarkerprofiles
AT sandrapietsch comparisonofperipheralandcentralschizophreniabiomarkerprofiles
AT tammymkcheng comparisonofperipheralandcentralschizophreniabiomarkerprofiles
AT emanuelschwarz comparisonofperipheralandcentralschizophreniabiomarkerprofiles
AT paulcguest comparisonofperipheralandcentralschizophreniabiomarkerprofiles
AT sabinebahn comparisonofperipheralandcentralschizophreniabiomarkerprofiles
_version_ 1724990958359019520